Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential ...

immune-mediated necrotizing myopathy, polymyositis, and overlap myositis. Enrolled patients will receive a single dose of ADI-001. The dose-limiting toxicity window is 28 days with response and ...

Patients with IIM who had probable or definite diagnoses of dermatomyositis, polymyositis, immune-mediated necrotizing myopathy, classic dermatomyositis rash, or biopsy indicating amyopathic disease ...

Peterson died from a rare immune disease, Immune-Mediated Necrotizing Myopathy (IMNM.) It’s a disease that causes severe muscle weakness and heart complications. He worked with Sanford Ambulance ...

Jon was an extraordinary husband, father of two girls, and paramedic who was diagnosed with Immune-Medicated Necrotizing Myopathy, a rare and debilitating disease that has drastically impacted his ...

Autologous 4-1BB Anti-CD19 CAR T Cell Therapy in Patients with Immune-Mediated Necrotizing Myopathy and Systemic Lupus Erythematosus from the RESET-MyositisTM and RESET-SLETM Clinical Trials ...

The first, immune-mediated necrotizing myopathy (IMNM) attacks muscles and generally can’t be treated with medications. The other, systemic sclerosis, is especially harrowing as it damages internal ...

Title: Correlative Studies of CABA-201, a Fully Human, Autologous 4-1BB Anti-CD19 CAR T Cell Therapy in Patients with Immune-Mediated Necrotizing Myopathy and Systemic Lupus Erythematosus from the ...